Women with schizophrenia to get new treatment option

May 26, 2014
Women with schizophrenia to get new treatment option

(Medical Xpress)—In a world first study, exciting new research has revealed that oestrogen can help treat schizophrenia in previously treatment-resistant women.

Led by Monash Alfred Psychiatry Research Centre (MAPrc) Professor Jayashri Kulkarni, the study is the first large-scale randomised-controlled trial in with treatment-resistant schizophrenia.

Conducted over several years, the research was deemed necessary after it was discovered that a specific focus for women with schizophrenia was lacking, with an urgent need for new treatment approaches.

The study, the largest clinical trial in the world of its type, found that in an eight week, three arm, double blind, placebo-controlled, adjunctive trial of estradiol, women who were given estradiol made better recoveries than those who were given a placebo.

Professor Kulkarni said persistent schizophrenia was common despite advances over the years in antipsychotic drug development, with little of the research focused on women.

"A specific focus for women with schizophrenia is still somewhat lacking and there is a real need to consider the special issues facing women with schizophrenia," Professor Kulkarni said.

"Since we are the pioneers in this area, with the optimal safe dose and delivery of estradiol being explored by our group in earlier , we felt this newer trial was necessary in the effective treatment of women with schizophrenia.

"What we found was that adjunctive estradiol treatment has practical use for women who have not responded well to antipsychotic drug treatment previously.

"We also found that due to the fluctuations of estrogen in women and its impact on mental state the premenstrual period, post natal and menopause phases of a woman's life are critical times for mental state changes. A team approach to her treatment is vital to the best health and mental health care outcomes."

Professor Kulkarni said she was excited about the positive results of the study, with trials of selective estrogen receptor modulators representing a hopeful future direction for schizophrenia research.

"There are many promising newer forms of hormone that offer great hope in the much-needed area of new, effective treatments for people with persistent and should be expanded to include men and postmenopausal women."

Explore further: Gender separation in psychiatry

Related Stories

Gender separation in psychiatry

June 3, 2013

(Medical Xpress)—Results in a study of Australia's first women-only psychiatry ward at The Alfred have been published in the prestigious Journal of Clinical Psychiatry.

Recommended for you

Babies need free tongue movement to decipher speech sounds

October 12, 2015

Inhibiting infants' tongue movements impedes their ability to distinguish between speech sounds, researchers with the University of British Columbia have found. The study is the first to discover a direct link between infants' ...

Women and men react differently to infidelity

October 8, 2015

If your partner has sex with someone else, it is considered infidelity - even if no emotions are involved. But it is also considered infidelity when your significant other develops a close personal relationship with someone ...

Repeating aloud to another person boosts recall

October 6, 2015

Repeating aloud boosts verbal memory, especially when you do it while addressing another person, says Professor Victor Boucher of the University of Montreal's Department of Linguistics and Translation. His findings are the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.